Annovis Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

By WebmasterJanuary 31, 2020November 1st, 2024No Comments

Annovis Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Previous PostChildren's National Hospital Partners with Bainbridge Health to Enhance Visibility on IV Medication Use Data
Next PostAnnovis Bio Announces Pricing of Initial Public Offering